Skip to product information
1 of 1

  • Images are for illustration purposes only
  • Gphc Registered
  • Join over 100k customers
  • Fixed prices and no subscriptions
  • Discreet next day delivery.
  • Free shipping on all orders over £50

Dymista Nasal Spray

Dymista Nasal Spray

  • 1. Ozempic®️-equivalent therapy now available for weight management
  • 2. Average weight loss of 17%, with 1 in 3 patients achieving over 20%
  • 3. May help reduce osteoarthritis-related pain
  • 4. Wegovy®️ is not expected to impact the effectiveness of oral contraceptives
  • 5. Supports cardiovascular risk reduction
  • 6. Over 22 million patients treated with semaglutide-based therapies since 2018

We’re proud to offer fast and discreet delivery for all our medicines & treatments.

Price Checker

Regular price £18.85
Sale price £18.85
Sale Sold out
  • Lowest price guarantee
  • Includes FREE private prescription
View full details

Buy Dymista Nasal Spray Online In The UK


Dymista
 Nasal Spray is a rapid action medication that works quickly to help treat your allergy symptoms such as sneezing, stuffy or runny nose, and itchy eyes. It’s frequently prescribed for people with moderate to severe hay fever or year-round allergies who have not gotten adequate relief from standard antihistamine or steroid sprays.
 

 

What makes Dymista different is that it combines two powerful ingredients in one spray: 

 

  • Azelastine, an antihistamine that helps quickly relieve itching, sneezing, and a runny nose. 

  • Fluticasone, a corticosteroid that reduces inflammation inside your nose, helping with swelling and congestion. 

 

They work faster and even stronger when used together than either one alone. Most people begin to notice an improvement within hours, with the full effect gradually building over a few days of regular use. 

 

Dymista is suitable for adults and children aged 12 years and over. It’s especially helpful during high pollen seasons or for anyone dealing with persistent allergy symptoms that interfere with daily life or sleep. 

Before Using Dymista Nasal Spray 

Give the bottle a little shake before using to ensure the ingredients are well incorporated. Prime the spray before first use by pumping several times, until a fine mist appears. If you haven’t used it in a while (a few days, for example), re-prime it with the same technique. 

Begin by blowing your nose to clear your nasal passages. Leaning your head forward, insert the nozzle into one nostril, and close the other with your finger. Breathe in gently through your nose as you spray, then repeat in the other nostril. Avoid tilting your head back after spraying so the medication doesn’t drip down your throat, and try not to blow your nose for a few minutes afterward. 

How to Use Dymista Nasal Spray 

Use Dymista two times each day — once in the morning and then once at night — unless your doctor has told you to do otherwise. Be sure to use it regularly through allergy season or when your symptoms strike.

 

If you miss a dose, use it when you remember (with one exception if it’s almost time for your next prescribed spray). Never double your dose to make up for a missed spray. Regular use is the best way to make sure this treatment works as well as possible. 

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)

Side Effects of Dymista Nasal Spray

Dymista is generally well-tolerated, but like all medicines, some people may experience side effects. These are usually mild and improve as your body adjusts.

Common side effects may include:

  • Headache
  • Bitter taste in the mouth
  • Sneezing shortly after use
  • Nasal discomfort or irritation
  • Nosebleeds

Less common side effects:

  • Dry or irritated throat
  • Cough
  • Dizziness
  • Fatigue
  • Changes in smell or taste

Rare side effects:

  • Severe nosebleeds
  • Signs of infection (persistent fever, thick nasal discharge)
  • Allergic reactions such as swelling or difficulty breathing (seek medical help immediately)

If any side effect becomes bothersome or persists, speak with your GP or pharmacist.

Patient Information Leaflet

Important - Before taking any medication, it is always important to read the Patient Information Leaflet (PIL)

Written and reviewed by our qualified team

GPhC Number: 2233073
Tarun Kumar

Reviewed by:

Tarun Kumar

Superintendent/ Clinical Lead

📖 Find out more about our team of medical content authors and how we ensure the accuracy of our content with our content guidelines.

Content last updated: 31 Mar 2025

We’re a safe and
regulated UK service

Registered Pharmacy Badge

Lowest Price Guarantee

We're convinced you won't find your treatment cheaper, but if you do we'll refund the difference.

Find out more

100% discreet packaging

We're convinced you won't find your treatment cheaper, but if you do we'll refund the difference.

Find out more

Agent

Need help?
Talk to our friendly experts now

How our service works

Service Setup

Service setup

Discreet Packaging

Discreet packaging

Express Delivery

Express delivery

Comparison of Weight Loss Injectables

Features

Mounjaro®

Injectable Pen

Wegovy®

Injectable Pen

Saxenda®

Injectable Pen

Active Ingredient Tirzepatide Semaglutide Liraglutide
Mechanism of Action GLP-1 and GIP receptor agonist GLP-1 receptor agonist GLP-1 receptor agonist
Administration Weekly injection Weekly injection Daily injection
Dosage Varies by patient, typically starting low Varies, typically starting at 0.25 mg Varies, starting at 0.6 mg
Effect on Appetite Significantly reduces appetite and cravings Reduces appetite and increases satiety Reduces appetite and increases satiety
Average Weight Loss Up to 20% body weight reduction Up to 15% body weight reduction Significant weight reduction
Side Effects Nausea, vomiting, diarrhoea, constipation Nausea, vomiting, diarrhoea, constipation Nausea, diarrhoea, constipation, hypoglycemia
Approval FDA-approved for weight loss FDA-approved for weight loss FDA-approved for weight loss
Suitable For Adults with BMI ≥30 or ≥27 with comorbidities Adults with BMI ≥30 or ≥27 with comorbidities Adults with BMI ≥30 or ≥27 with comorbidities